Properties of the Novel Chinese Herbal Medicine Formula Qu Du Qiang Fei I Hao Fang Warrant Further Research to Determine Its Clinical Efficacy in COVID-19 Treatment
- 1 February 2021
- journal article
- research article
- Published by Mary Ann Liebert Inc in Medical Acupuncture
- Vol. 33 (1), 71-82
- https://doi.org/10.1089/acu.2020.1466
Abstract
Introduction: COVID-19, the infectious disease induced by the virus severe acute respiratory syndrome-related coronavirus-2, has caused increasing global health concerns, and novel strategies to prevent or ameliorate the condition are needed. Traditional Chinese Medicine (TCM) herbal formulas have been used in the treatment of epidemics in China for over 2000 years. This study investigated the therapeutic effects of Qu Du Qiang Fei I Hao Fang (QDQF1) “Eliminating Virus and Strengthening Lung—No.1 Formula,” in the treatment and prevention of COVID-19. QDQF1 consists of Shēng Huáng Qí, Běi Shā Shēn, Chuān Jié Gěng, Zhì Fáng Fēng, Qīng Lián Qiáo, Jīn Yín Huā, Bǎn Lán Gēn, Chǎo Cāng Zhú, Zǐ Huā Dì Dīng, and Shēng gān căo. Materials and Methods: A literature survey was performed by conducting systematic electronic searches in PubMed, Science Direct, Google Scholar, and in books. Results: Each herb in this formula has long been used to treat various diseases due to their pharmacologic, antiviral, anti-inflammatory, and antimicrobial effects that inhibit microbial adherence to mucosal or epithelial surfaces, inhibit endotoxin shock, and selectively inhibit microbial growth. Conclusion: The herbs chosen for the QDQF1 formula have been historically paired, and cast a wide net over the potential COVID-19 symptomatology. Their combined functions provide comprehensive and balanced therapeutics from both TCM and allopathic perspectives. Individual herbs and herbal combinations are analyzed for their applicability to pertinent TCM patterns of COVID-19 presentations, including heat and cold patterns, damp and phlegm syndromes, toxicity, and deficiency patterns. A further study in a randomized, double-blind, and placebo-controlled trial of QDQF1 is recommended to assess its therapeutic efficacy in the treatment of COVID-19.Keywords
This publication has 55 references indexed in Scilit:
- In VivoAnti-Influenza Virus Activity of Japanese Herbal (Kampo) Medicine, “Shahakusan,” and Its Possible Mode of ActionEvidence-Based Complementary and Alternative Medicine, 2012
- Oseltamivir Compared With the Chinese Traditional Therapy Maxingshigan–Yinqiaosan in the Treatment of H1N1 InfluenzaAnnals of Internal Medicine, 2011
- Anti-inflammatory Activity of Methylene Chloride Fraction From Glehnia littoralis Extract via Suppression of NF-κB and Mitogen-Activated Protein Kinase ActivityJournal of Pharmacological Sciences, 2010
- Chemical Constituents of Viola yedoensisChinese Journal of Natural Medicines, 2009
- Chemical Constituents of Viola yedoensisChinese Journal of Natural Medicines, 2009
- Anti-HIV Cyclotides from the Chinese Medicinal Herb Viola yedoensisJournal of Natural Products, 2007
- Antibacterial activity of the Chinese traditional medicine, Zi Hua Di DingPhytotherapy Research, 2004
- Antibacterial and Antifungal Polyine Compounds fromGlehnia littoralisssp.leiocarpaPlanta Medica, 1996
- Protective Effect of Astragali Radix by Intraperitoneal Injection against Japanese Encephalitis Virus Infection in Mice.Biological & Pharmaceutical Bulletin, 1996
- The major pectic arabinogalactan having activity on the reticuloendothelial system from the roots and rhizomes of Saposhnikovia divaricata.CHEMICAL & PHARMACEUTICAL BULLETIN, 1989